<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="Publisher" Owner="NLM">        <PMID Version="1">30419307</PMID>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>12</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1879-355X</ISSN>                <JournalIssue CitedMedium="Internet">                    <PubDate>                        <Year>2018</Year>                        <Month>Nov</Month>                        <Day>09</Day>                    </PubDate>                </JournalIssue>                <Title>International journal of radiation oncology, biology, physics</Title>                <ISOAbbreviation>Int. J. Radiat. Oncol. Biol. Phys.</ISOAbbreviation>            </Journal>            <ArticleTitle>Nomogram predicting locoregional recurrence to assist decision-making of postmastectomy radiotherapy in patients with T1-2N1 breast cancer.</ArticleTitle>            <ELocationID EIdType="pii" ValidYN="Y">S0360-3016(18)33952-X</ELocationID>            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijrobp.2018.11.005</ELocationID>            <Abstract>                <AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Postmastectomy radiotherapy (PMRT) showed heterogeneous effects on survival outcome of patients with T1-2N1 breast cancer. A reliable model to estimate individuals' risk of locoregional recurrence (LRR) and the potential benefit derived from PMRT is in need.</AbstractText>                <AbstractText Label="METHODS AND MATERIALS" NlmCategory="METHODS">We retrospectively analyzed 1141 patients with T1-2N1 breast cancer who underwent mastectomy between January 2001 and December 2012. Based on the Fine and Gray competing risks regression in 623 unirradiated patients, a nomogram predicting LRR was conducted for risk quantification. Decision tree analysis was performed for patient grouping. The impact of PMRT was evaluated among three subgroups.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">With a median follow-up of 74.9 months, the five-year cumulative incidence of LRR, distant recurrence (DR) and breast cancer mortality (BCM) were 3.9%, 8.8% and 6.0% for the entire cohort. Based on nomogram scores, patients were classified into three risk groups in decision tree analysis. In high-risk group, PMRT was found to be associated with a 12.7% risk reduction of 5-year LRR, 9.2% risk reduction of 5-year DR and 7.0% risk reduction of 5-year BCM, while it was not significantly associated with LRR, DR or BCM in low- and intermediate-risk groups.</AbstractText>                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The nomogram performed individualized risk quantification of LRR in patients with T1-2N1 breast cancer. A newly identified patient subgroup with high risk of LRR were found to derive survival benefit from PMRT.</AbstractText>                <CopyrightInformation>Copyright Â© 2018 Elsevier Inc. All rights reserved.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Luo</LastName>                    <ForeName>Chuanxu</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>Laboratory of Molecular Diagnosis of Cancer &amp; Breast Medical Oncology, Clinical Research Center for Breast, West China Hospital, Sichuan University, Chengdu, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Zhong</LastName>                    <ForeName>Xiaorong</ForeName>                    <Initials>X</Initials>                    <AffiliationInfo>                        <Affiliation>Laboratory of Molecular Diagnosis of Cancer &amp; Breast Medical Oncology, Clinical Research Center for Breast, West China Hospital, Sichuan University, Chengdu, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Deng</LastName>                    <ForeName>Ling</ForeName>                    <Initials>L</Initials>                    <AffiliationInfo>                        <Affiliation>Laboratory of Molecular Diagnosis of Cancer &amp; Breast Medical Oncology, Clinical Research Center for Breast, West China Hospital, Sichuan University, Chengdu, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Xie</LastName>                    <ForeName>Yuxin</ForeName>                    <Initials>Y</Initials>                    <AffiliationInfo>                        <Affiliation>Laboratory of Molecular Diagnosis of Cancer &amp; Breast Medical Oncology, Clinical Research Center for Breast, West China Hospital, Sichuan University, Chengdu, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Hu</LastName>                    <ForeName>Kejia</ForeName>                    <Initials>K</Initials>                    <AffiliationInfo>                        <Affiliation>Laboratory of Molecular Diagnosis of Cancer &amp; Breast Medical Oncology, Clinical Research Center for Breast, West China Hospital, Sichuan University, Chengdu, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Zheng</LastName>                    <ForeName>Hong</ForeName>                    <Initials>H</Initials>                    <AffiliationInfo>                        <Affiliation>Laboratory of Molecular Diagnosis of Cancer &amp; Breast Medical Oncology, Clinical Research Center for Breast, West China Hospital, Sichuan University, Chengdu, China. Electronic address: hzheng@scu.edu.cn.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>11</Month>                <Day>09</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>Int J Radiat Oncol Biol Phys</MedlineTA>            <NlmUniqueID>7603616</NlmUniqueID>            <ISSNLinking>0360-3016</ISSNLinking>        </MedlineJournalInfo>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>03</Month>                <Day>13</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="revised">                <Year>2018</Year>                <Month>10</Month>                <Day>16</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>11</Month>                <Day>02</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>11</Month>                <Day>13</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>11</Month>                <Day>13</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>11</Month>                <Day>13</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>aheadofprint</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30419307</ArticleId>            <ArticleId IdType="pii">S0360-3016(18)33952-X</ArticleId>            <ArticleId IdType="doi">10.1016/j.ijrobp.2018.11.005</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>